[Anti-CD19 chimeric antigen receptors T cells for treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: three cases report and literatures review].
作者信息
Yang F, Zhang J, Qiu H Y, Wu Q, Kong D Q, Han J J, Qi J Q, Han Y, Wu D P
机构信息
Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
出版信息
Zhonghua Xue Ye Xue Za Zhi. 2018 Jan 14;39(1):47-49. doi: 10.3760/cma.j.issn.0253-2727.2018.01.010.
Abstract
摘要
相似文献
1
[Anti-CD19 chimeric antigen receptors T cells for treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: three cases report and literatures review].
Zhonghua Xue Ye Xue Za Zhi. 2018 Jan 14;39(1):47-49. doi: 10.3760/cma.j.issn.0253-2727.2018.01.010.
2
Anti-CD19 chimeric antigen receptors T cells for the treatment of relapsed or refractory E2A-PBX1 positive acute lymphoblastic leukemia: report of three cases.
Leuk Lymphoma. 2019 Jun;60(6):1454-1461. doi: 10.1080/10428194.2018.1533127. Epub 2019 Feb 4.
3
4
Rational design of an immunoconjugate for selective knock-down of leukemia-specific E2A-PBX1 fusion gene expression in human Pre-B leukemia.
Integr Biol (Camb). 2013 Jan;5(1):122-32. doi: 10.1039/c2ib20114c.
5
6
A review of CD19-targeted immunotherapies for relapsed or refractory acute lymphoblastic leukemia.
J Oncol Pharm Pract. 2018 Sep;24(6):453-467. doi: 10.1177/1078155217713363. Epub 2017 Jun 5.
7
E2a/Pbx1 induces the rapid proliferation of stem cell factor-dependent murine pro-T cells that cause acute T-lymphoid or myeloid leukemias in mice.
Mol Cell Biol. 2004 Feb;24(3):1256-69. doi: 10.1128/MCB.24.3.1256-1269.2004.
8
Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.
J Hematol Oncol. 2016 Nov 25;9(1):131. doi: 10.1186/s13045-016-0357-z.
9
[Chimeric antigen receptors T cells for treatment of 48 relapsed or refractory acute lymphoblastic leukemia children: long term follow-up outcomes].
Zhonghua Xue Ye Xue Za Zhi. 2019 Apr 14;40(4):270-275. doi: 10.3760/cma.j.issn.0253-2727.2019.04.002.
10
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial.
Lancet Haematol. 2022 Nov;9(11):e833-e843. doi: 10.1016/S2352-3026(22)00245-9. Epub 2022 Oct 10.
本文引用的文献
1
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells.
Sci Transl Med. 2017 Jan 25;9(374). doi: 10.1126/scitranslmed.aaj2013.
2
CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date.
Blood. 2016 Jun 30;127(26):3312-20. doi: 10.1182/blood-2016-02-629063. Epub 2016 May 20.
3
CD19 CAR-T cells of defined CD4+:CD8+ composition in adult B cell ALL patients.
J Clin Invest. 2016 Jun 1;126(6):2123-38. doi: 10.1172/JCI85309. Epub 2016 Apr 25.
4
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy.
Cancer Discov. 2015 Dec;5(12):1282-95. doi: 10.1158/2159-8290.CD-15-1020. Epub 2015 Oct 29.
5
Management and treatment of relapsed or refractory Ph(-) B-precursor ALL: a web-based, double-blind survey of EU clinicians.
BMC Cancer. 2015 Oct 24;15:771. doi: 10.1186/s12885-015-1745-4.
6
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia.
Sci Transl Med. 2014 Feb 19;6(224):224ra25. doi: 10.1126/scitranslmed.3008226.
7
Adoptive immunotherapy for B-cell malignancies with autologous chimeric antigen receptor modified tumor targeted T cells.
Discov Med. 2010 Apr;9(47):277-88.
8
Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study.
Leukemia. 2006 Dec;20(12):2155-61. doi: 10.1038/sj.leu.2404420. Epub 2006 Oct 12.
9
Outcome of 609 adults after relapse of acute lymphoblastic leukemia (ALL); an MRC UKALL12/ECOG 2993 study.
Blood. 2007 Feb 1;109(3):944-50. doi: 10.1182/blood-2006-05-018192. Epub 2006 Oct 10.
10
Molecular diagnosis and clinical relevance of t(9;22), t(4;11) and t(1 ;19) chromosome abnormalities in a consecutive group of 141 adult patients with acute lymphoblastic leukemia.
Leuk Lymphoma. 1996 May;21(5-6):457-66. doi: 10.3109/10428199609093444.
Zotero 插件